A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of ...

A higher adherence to a Mediterranean diet is linked to a lower risk of developing MS, particularly in nonsmokers and people ...

Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

Dancing the night away with an old friend reminded columnist Susan Payrovi, MD, how much she benefits from seeking joy and connection.

A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar treatment ...

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...

Columnist Ben Hofmeister likens the three battlefield ways to degrade an adversary's abilities to the disruptions caused by ...